Mumbai: Marksans Pharma Limited has announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna ...
AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...
Marksans Pharma added 2.22% to Rs 207.35 after the company announced that its Goa-based manufacturing facility has been approved by Australian TGA for manufacture of pharmaceutical formulations for ...
Dublin: BrePco Biopharma Limited (BPCO) that develops products for the unique needs of paediatric patients and Piramal ...
Baclofen is a muscle relaxant primarily prescribed to treat muscle spasms, cramping, and tightness associated with multiple ...
StockStory.org on MSN18 小时
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded ...The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...
Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:45 Hrs [IST] Sovereign Pharma, ...
Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...
Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果